Live from the NIH registry
Studies recruiting near Las Vegas right now
Top 25 of 437 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Angiokeratomas
Phase 2
Interventional 15 participants sought
Vividia Dermatology — Las Vegas, Nevada (8.2 mi)
· Sponsor: Palvella Therapeutics, Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Las Vegas Clinical Trials — North Las Vegas, Nevada (8.6 mi)
· Sponsor: Crystalys Therapeutics
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Las Vegas, Nevada (8.2 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
AB Clinical Trials — Las Vegas, Nevada (8.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Jubilee Clinical Research, Inc. — Las Vegas, Nevada (8.2 mi)
· Sponsor: Novo Nordisk A/S
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 220 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (8.2 mi)
· Sponsor: Circle Pharma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (8.2 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Excel Clinical Research — Las Vegas, Nevada (8.2 mi)
· Sponsor: Biomea Fusion Inc.
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Sheldon Freedman MD, Ltd — Las Vegas, Nevada (8.2 mi)
· Sponsor: Urotronic Inc.
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 21 — North Las Vegas, Nevada (8.6 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Uterine Fibroids, Leiomyoma
N/A
Interventional 42 participants sought
Citruslabs — Las Vegas, Nevada (8.2 mi)
· Sponsor: Zenchi, Inc.
Shoulder Innovations Clinical Data Registry
Shoulder Arthroplasty
N/A
Observational 2,500 participants sought
University Medical Center of Southern Nevada — Las Vegas, Nevada (8.2 mi)
· Sponsor: Shoulder Innovations
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
Recurrent or Metastatic Solid Tumors
Phase 1
Interventional 76 participants sought
Research Site — Las Vegas, Nevada (8.2 mi)
· Sponsor: Daiichi Sankyo
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Las Vegas, Nevada (8.2 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Las Vegas, Nevada (8.2 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada (8.2 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Las Vegas, Nevada (8.2 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
ADHD, Sleep Disturbance
N/A
Interventional 90 participants sought
Citruslabs — Las Vegas, Nevada (8.2 mi)
· Sponsor: Outliers, Inc.
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Palm Research Center, Inc. — Las Vegas, Nevada (8.2 mi)
· Sponsor: Zucara Therapeutics Inc.
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-072 — Las Vegas, Nevada (8.2 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 500 participants sought
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley — Las Vegas, Nevada (8.2 mi)
· Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Smoking
Phase 2
Interventional 222 participants sought
Vector Clinical Trials — Las Vegas, Nevada (8.2 mi)
· Sponsor: Eli Lilly and Company
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
OptumCare Cancer Care at Charleston — Las Vegas, Nevada (8.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2
Interventional 90 participants sought
Hendersen, Navada — Henderson, Nevada (20.7 mi)
· Sponsor: Centessa Pharmaceuticals (UK) Limited
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Phase 3
Interventional 1,314 participants sought
OptumCare Cancer Care-Research Department ( Site 0078) — Las Vegas, Nevada (8.2 mi)
· Sponsor: Merck Sharp & Dohme LLC